AssetMark Inc’s Akero Therapeutics AKRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$76.8K Buy
1,439
+870
+153% +$46.4K ﹤0.01% 1431
2025
Q1
$23K Buy
+569
New +$23K ﹤0.01% 1671